Compare AMPH & ETW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMPH | ETW |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.8M | 1.0B |
| IPO Year | 2005 | 2005 |
| Metric | AMPH | ETW |
|---|---|---|
| Price | $16.84 | $9.20 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.38 | N/A |
| AVG Volume (30 Days) | ★ 544.9K | 235.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $719,887,000.00 | N/A |
| Revenue This Year | $6.90 | N/A |
| Revenue Next Year | $4.64 | N/A |
| P/E Ratio | $124.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.03 | $8.22 |
| 52 Week High | $31.26 | $9.60 |
| Indicator | AMPH | ETW |
|---|---|---|
| Relative Strength Index (RSI) | 31.72 | 44.22 |
| Support Level | N/A | $9.11 |
| Resistance Level | $24.16 | $9.22 |
| Average True Range (ATR) | 0.86 | 0.08 |
| MACD | -0.62 | -0.02 |
| Stochastic Oscillator | 2.44 | 1.54 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.